首页|微小RNA-124和RNA-1976在帕金森病患者血清中的表达及临床价值

微小RNA-124和RNA-1976在帕金森病患者血清中的表达及临床价值

扫码查看
目的 探讨微小RNA-124(miR-124)和RNA-1976(miR-1976)在帕金森病(PD)患者血清中的表达及临床意义.方法 选取2020年9月至2022年6月在我院治疗的原发性PD患者58例为PD组,采用统一帕金森病评定量表(UPDRS)评分对PD患者分为UPDRS≤60分(25例)和UPDRS>60分(33例)两组,并进行Hoehn-Yahr分级.同时选择同期体检健康者30例为对照组.收集研究对象血清后,采用实时荧光定量PCR(qRT-PCR)技术检测血清中miR-124和miR-1976的表达水平.采用Logistic回归分析法分析影响因素,采用受试者工作特征(ROC)曲线分析血清miR-124、miR-1976对PD的诊断价值.利用TargetScan、miRTarbase等多个预测软件对miR-1976的靶基因进行分析.结果 与对照组相比,PD组血清miR-124表达下调[(1.49±0.36)比(1.02± 0.32)](t=8.85,P<0.001),miR-1976 表达上调[(0.98±0.30)比(1.33±0.37)](t=6.92,P<0.001);血清miR-124低表达、miR-1976高表达是PD发生的独立危险因素(OR>1,P<0.05);UPDRS评分>60分的PD患者Hoehn-Yahr分级明显高于UPDRS≤60分的患者[(3.42±0.73)比(2.16±0.42)]差异有统计学意义(t=3.05,P<0.05),但血清miR-124、miR-1976表达水平差异无统计学意义[miR-124:(1.09±0.26)比(0.98±0.38);miR-1976:(1.42±0.43)比(1.23±0.68)](t=0.89,0.62,均P>0.05);ROC结果显示,血清miR-124、miR-1976诊断PD的曲线下面积(AUC)分别为0.832、0.797,截断值分别为1.205、1.196,对应灵敏度分别为74.1%、51.8%,特异度分别为77.8%、90.1%;二者联合诊断PD的AUC为0.912,灵敏度为76.4%,特异度为93.2%.PINK1基因为miR-1976的潜在靶基因.结论 PD患者血清miR-124表达水平降低,miR-1976表达水平升高,二者均对PD诊断有一定参考价值,且联合诊断价值更高,但二者表达水平与UPDRS评分无关.
Expression and clinical value of miR-124 and miR-1976 in serum of patients with Parkinson's disease
Objective To investigate the expression and clinical significance of microRNA-124(miR-124)and microRNA-1976(miR-1976)in the serum of patients with Parkinson's disease(PD).Methods A total of 58 patients with PD were selected from September 2020 to June 2022 and categorized as the PD group.The Unified Parkinson's Disease Rating Scale(UPDRS)score was used to divide the PD patients into two groups:those with a UPDRS score≤60(25 patients)and those with a UPDRS score>60(33 patients).The Hoehn-Yahr grading scale was used to grade the PD patients.Additionally,30 healthy individuals who had undergone a physical examination during the same period were selected as the control group.After collecting the subjects'serum,we performed real-time fluorescent quantitative PCR(qRT-PCR)to detect the expressions of miR-124 and miR-1976 in the serum.Logistic regression analysis was employed to analyze the influencing factors,and the diagnostic significance of serum miR-124 and miR-1976 in PD patients was evaluated using the receiver operating characteristic(ROC)curve.To predict the target genes of miR-1976,we utilized several software including TargetScan and Mirtarbase.Results Compared to the control group,the PD group showed a significant down-regulation of serum miR-124 expression[(1.49±0.36)vs.(1.02± 0.32)](t=8.85,P<0.001),while miR-1976 expression was sharply up-regulated[(0.98±0.30)vs.(1.33±0.37)](t=6.92,P<0.001).The low expression of serum miR-124 and the overexpression of miR-1976 were identified as independent risk factors for PD(OR>1,P<0.05).The Hoehn-Yahr rating of PD patients with a UPDRS score above 60 was higher than that of patients with a UPDRS score below 60[(3.42±0.73)vs.(2.16±0.42)](t=3.05,P<0.05).However,there was no significant difference in serum miR-124 and miR-1976 expression between groups with different UPDRS scores[miR-124:(1.09±0.26)vs.(0.98±0.38)(t=0.89,P>0.05);miR-1976:(1.42± 0.43)vs.(1.23±0.68)(t=0.62,P>0.05)].The ROC analysis results demonstrated that miR-124 and miR-1976 had area under the curve(AUC)values of 0.832 and 0.797,respectively,in diagnosing PD.The corresponding cutoff values were 1.205 and 1.196,respectively.The sensitivity for miR-124 was 74.1%,while for miR-1976 it was 51.8%.The specificity for miR-124 was 77.8%,and for miR-1976 it was 90.1%.When both miR-124 and miR-1976 were combined in the diagnosis of PD,the AUC was 0.912,with a sensitivity of 76.4%and a specificity of 93.2%.Furthermore,it was found that miR-1976 targeted the PINK1 gene,suggesting its potential as a target gene in PD.Conclusions The expression of miR-124 was found to be decreased in PD patients,while the expression of miR-1976 was increased.Both miR-124 and miR-1976 showed some reference value in PD diagnosis,and their combined diagnostic value was higher.This suggests that further study on their significance is warranted.However,it should be noted that the expressions of miR-124 and miR-1976 were not found to be correlated with the UPDRS score of PD patients.

Parkinson's diseaseMicroRNA-124MicroRNA-1976UPDRS scoreClinical diagnosis value

陈婷、陈浩、师亮、闫卫红、丁智斌、姬浩宇、张萌、李新毅

展开 >

山西医科大学第三医院(山西白求恩医院 山西医学科学院 同济山西医院),太原 030032

山西白求恩医院(山西医学科学院 同济山西医院),山西医科大学第三医院,太原 030032

华中科技大学同济医学院附属同济医院,武汉 430030

山西医科大学基础医学院,太原 030001

展开 >

帕金森病 微小RNA-124 微小RNA-1976 UPDRS评分 诊断价值

国家自然科学基金山西省基础研究计划山西省基础研究计划山西省青年科技研究基金山西白求恩医院院级科研基金

8117345520230302121124720210302122435020150211892021YJ03

2024

中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
年,卷(期):2024.43(1)
  • 2